Range Low Price High Price Comment
30 days $15.12 $18.49 Thursday, 28th Mar 2024 VRNA stock ended at $16.09. This is 2.48% less than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 5.85% from a day low at $15.80 to a day high of $16.73.
90 days $15.12 $20.67
52 weeks $11.83 $23.81

Historical Verona Pharma plc prices

Date Open High Low Close Volume
2023-07-19 $21.08 $21.22 $20.66 $20.98 276 858
2023-07-18 $21.68 $21.84 $21.07 $21.07 202 854
2023-07-17 $22.09 $23.07 $21.69 $21.74 400 631
2023-07-14 $21.85 $22.21 $21.11 $22.09 394 427
2023-07-13 $21.04 $22.00 $20.74 $21.73 584 492
2023-07-12 $20.43 $21.25 $20.17 $20.99 448 944
2023-07-11 $20.25 $20.40 $19.83 $20.34 281 015
2023-07-10 $19.84 $20.30 $19.53 $20.28 331 148
2023-07-07 $20.11 $20.46 $19.86 $19.92 293 755
2023-07-06 $20.55 $20.68 $20.05 $20.15 313 770
2023-07-05 $20.21 $20.76 $20.12 $20.65 688 214
2023-07-03 $21.15 $21.52 $19.56 $20.13 332 511
2023-06-30 $20.90 $21.36 $20.90 $21.14 346 773
2023-06-29 $20.96 $20.96 $20.54 $20.80 346 873
2023-06-28 $20.28 $20.95 $20.24 $20.76 377 726
2023-06-27 $20.96 $20.96 $19.65 $20.22 613 580
2023-06-26 $21.34 $21.62 $20.26 $20.64 684 844
2023-06-23 $21.47 $21.70 $21.16 $21.52 473 689
2023-06-22 $21.56 $22.25 $21.43 $21.61 608 465
2023-06-21 $21.49 $21.87 $21.15 $21.63 495 739
2023-06-20 $21.24 $21.54 $21.21 $21.49 224 435
2023-06-16 $21.00 $21.65 $21.00 $21.23 457 379
2023-06-15 $21.54 $21.54 $20.72 $21.12 486 580
2023-06-14 $21.63 $22.18 $21.44 $21.51 240 209
2023-06-13 $21.83 $22.57 $21.65 $21.75 543 852
Click to get the best stock tips daily for free!

About Verona Pharma plc

Verona Pharma plc Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the ... VRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT